title: Dystonia in a patient with melanoma metastatic to the brain treated with high-dose interleukin-2, radiation therapy, and levetiracetam.
abstract: Dystonia has been described as a potential toxicity of radiation therapy. Management of this rare movement disorder is targeted in symptom improvement. We report a case of a 46-year-old female patient who developed dystonia during treatment of melanoma metastatic to the brain and discuss potential causes of and therapies for this rare complication.
authors: Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, Minn., USA.
authors: Varun
authors: V
authors: Sreenivasan
authors: Arkadiusz Z
authors: AZ
authors: Dudek
keywords: Brain metastasis; Dystonia; Gamma Knife therapy; High-dose interleukin-2; Levetiracetam; Melanoma